Pharma & Biotech
Coronavirus
Cannabis
Battery Metals
Psychedelics
Benchmark sees long-term growth in aquaculture
Synairgen focuses on chronic obstructive pulmonary disease candidate supporting coronavirus programme
Polar Capital Global Healthcare looking for opportunities as healthcare market changes
Only registered members can use this feature.
or
© Proactive Investors 2020.
Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority. Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.
Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use.
